Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Increased cerebrospinal fluid levels of neurotrophin 3 (NT-3) in elderly patients with major depression

Abstract

Neurotrophin 3 (NT-3) is a member of the neurotrophin gene family which supports the survival of specific neurons. NT-3 was shown to prevent the death of adult central noradrenergic neurons in vivo, a neuronal population which is associated with the pathophysiology of major depression. We quantitated CSF levels of NT-3 in elderly patients with major depression (DE) and compared them to patients with Alzheimer's disease (AD), and mentally healthy control subjects (CTR). CSF levels of NT-3 were markedly and significantly elevated in the DE group, as compared to either the AD or the CTR group (P < 0.01, and P < 0.001, respectively). in terms of diagnostic accuracy, measurement of nt-3 levels in de resulted in 73.9% sensitivity, and 89.7% specificity. increased csf levels of nt-3 may indicate a disturbance of the central noradrenergic system in patients with de. nt-3 may constitute a biochemical candidate marker for clinical diagnosis and for the evaluation of therapeutic strategies in de.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Bothwell M . Functional interactions of neurotrophins and neurotrophin receptors Annu Rev Neurosci 1995; 18: 223–253

    Article  CAS  PubMed  Google Scholar 

  2. Price DL, Tanzi RE, Borchelt DR, Sisodia SS . Alzheimer's disease: genetic studies and transgenic models Annu Rev Genet 1998; 32: 461–493

    Article  CAS  PubMed  Google Scholar 

  3. Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP et al. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra Nature 1991; 350: 230–232

    Article  CAS  PubMed  Google Scholar 

  4. Knüsel B, Winslow JW, Rosenthal A, Burton LE, Seid DP, Nicolics K et al. Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3 Proc Natl Acad Sci USA 1991; 88: 961–965

    Article  PubMed  PubMed Central  Google Scholar 

  5. Mamounas LA, Blue ME, Siuciak JA, Altar CA . Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain J Neurosci 1995; 15: 7929–7939

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Arenas E, Persson H . Neurotrophin-3 prevents the death of adult central noradrenergic neurons in vivo Nature 1994; 367: 368–371

    Article  CAS  PubMed  Google Scholar 

  7. Leonard BE . The role of noradrenaline in depression: a review J Psychopharmacol 1997; 11: S39–S47

    CAS  PubMed  Google Scholar 

  8. Gall CM, Gold SJ, Isackson PJ, Seroogy KB . Brain-derived neurotrophic factor and neurotrophin-3 mRNAs are expressed in ventral midbrain regions containing dopaminergic neurons Mol Cell Neurosci 1992; 3: 56–63

    Article  CAS  PubMed  Google Scholar 

  9. Lindholm D, Hamner S, Zirrgiebel U . Neurotrophins and cerebellar development Perspect Dev Neurobiol 1997; 5: 83–94

    CAS  PubMed  Google Scholar 

  10. Maisonpierre PC, Belluscio L, Squinto S, Ip NY, Furth ME, Lindsay RM et al. Neurotrophin-3: a neurotrophic factor related to NGF and BDNF Science 1990; 247: 1146–1451

    Article  Google Scholar 

  11. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlau EM . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 1984; 34: 939–944

    Article  CAS  PubMed  Google Scholar 

  12. Folstein MF, Folstein SE, McHugh PR . Mini Mental State. A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 1975; 12: 189–198

    Article  CAS  PubMed  Google Scholar 

  13. Spiegel R, Brunner C, Ermini-Funfschilling D, Monsch A, Notter M, Puxty J et al. A new behavioral assessment scale for geriatric out- and in-patients: the NOSGER (Nurses’ Observation Scale for Geriatric Patients) J Am Geriatr Soc 1991; 39: 339–347

    Article  CAS  PubMed  Google Scholar 

  14. Montgomery SA, Asberg M . A new depression scale designed to be sensitive to change Br J Psychiatry 1979; 134: 382–389

    Article  CAS  PubMed  Google Scholar 

  15. McDowell IF, Wisdom GB, Trimble ER . Apolipoprotein E phenotype determined by agarose gel electrofocusing and immunoblotting Clin Chem 1989; 35: 2070–2073

    CAS  PubMed  Google Scholar 

  16. Hansen PS, Gerdes LU, Klausen IC, Gregersen N, Faergeman O . Genotyping compared with protein phenotyping of the common apolipoprotein E polymorphism Clin Chim Acta 1994; 224: 131–137

    Article  CAS  PubMed  Google Scholar 

  17. Leonard BE . The role of noradrenaline in depression: a review J Psychopharmacol 1997; 11: S39–S47

    CAS  PubMed  Google Scholar 

  18. Gilmore JH, Jarskog LF, Lindgren JC, McEvoy JP, Xiao H . Neurotrophin-3 levels in the cerebrospinal fluid of patients with schizophrenia or medical illness Psychiatry Res 1997; 73: 109–113

    Article  CAS  PubMed  Google Scholar 

  19. Murase K, Igarashi K, Hayashi K . Neurotrophin-3 (NT-3) levels in the developing rat nervous system and in human samples Clin Chim Acta 1994; 227: 23–36

    Article  CAS  PubMed  Google Scholar 

  20. Kunugi H, Hattori M, Ueki A, Isse K, Hirasawa H, Nanko S . Possible association of missense mutation (Gly[-63]Glu) of the neurotrophin-3 gene with Alzheimer's disease in Japanese Neurosci Lett 1998; 241: 65–67

    Article  CAS  PubMed  Google Scholar 

  21. Smith MA, Makino S, Altemus M, Michelson D, Hong SK, Kvetnansky R et al. Stress and antidepressants differentially regulate neurotrophin 3mRNA expression in the locus coeruleus Proc Natl Acad Sci USA 1995; 92: 8788–8792

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Nibuya M, Morinobu S, Duman RS . Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments J Neurosci 1995; 15: 7539–7547

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Duman RS, Heninger GR, Nestler EJ . A molecular and cellular theory of depression Arch Gen Psychiatry 1997; 54: 597–606

    Article  CAS  PubMed  Google Scholar 

  24. Altar CA . Neurotrophins and depression Trends Pharmacol Sci 1999; 20: 59–61

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by Grants 3100–049397.96/1 (Schweizerischer Nationalfonds) (UO, CH, FM-S), and SFB505 (Deutsche Forschungsgemeinschaft) (UO). We thank F Jancu for technical support and K Kräuchi, PhD, for help in statistical analyses.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C Hock.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hock, C., Heese, K., Müller-Spahn, F. et al. Increased cerebrospinal fluid levels of neurotrophin 3 (NT-3) in elderly patients with major depression. Mol Psychiatry 5, 510–513 (2000). https://doi.org/10.1038/sj.mp.4000743

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4000743

Keywords

  • noradrenaline
  • basal forebrain
  • neurotrophins
  • ELISA
  • aging

This article is cited by

Search

Quick links